1FTW
STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source details | OTHER |
Temperature [K] | 298 |
Detector technology | AREA DETECTOR |
Collection date | 1996-03-29 |
Detector | NICOLET IPC |
Spacegroup name | P 43 21 2 |
Unit cell lengths | 128.500, 128.500, 116.300 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 15.500 - 2.360 |
R-factor | 0.174 * |
Rwork | 0.174 |
R-free | 0.21400 |
Structure solution method | OTHER |
Starting model (for MR) | 2prj |
RMSD bond length | 0.008 |
RMSD bond angle | 1.400 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | CCP4 |
Refinement software | X-PLOR (3.851) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 15.500 | 2.470 |
High resolution limit [Å] | 2.360 | 2.360 |
Rmerge | 0.080 | |
Total number of observations | 145220 * | |
Number of reflections | 32684 | |
Completeness [%] | 81.0 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | unknown * | 6.7 | 16 * | Oikonomakos, N.G., (1985) Biochim.Biophys.Acta., 832, 248. * |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | 1 | phosphorylase b | 27.5 (mg/ml) | |
2 | 1 | 1 | IMP | 1.1 (mM) | |
3 | 1 | 1 | spermine | 1.1 (mM) | |
4 | 1 | 1 | Bes | 10 (mM) | |
5 | 1 | 1 | dithiothreitol | 2.9 (mM) | |
6 | 1 | 1 | EDTA | 0.1 (mM) |